Bobak R. Azamian Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Bobak R. Azamian is President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 1,750 shares of TARS, which is worth approximately $126,350. The most recent transaction as insider was on Dec 04, 2025, when has been sold 51,885 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.75K

96.74% 3M change

93.39% 12M change

Total Value Held $126,350

Bobak R. Azamian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 04 2025	SELL Bona fide gift	-	51,885 Reduced 96.74%	1,750 Common Stock
Mar 20 2025	SELL Open market or private sale	$427,638 $50.11 p/Share	8,534 Reduced 13.73%	53,635 Common Stock
Mar 19 2025	SELL Open market or private sale	$405,317 $47.4 p/Share	8,551 Reduced 12.09%	62,169 Common Stock
Mar 18 2025	SELL Open market or private sale	$330,093 $46.29 p/Share	7,131 Reduced 9.16%	70,720 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	51,395 Added 39.77%	77,851 Common Stock
Mar 18 2024	SELL Open market or private sale	$318,699 $30.6 p/Share	10,415 Reduced 28.25%	26,456 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	28,274 Added 43.4%	36,871 Common Stock

Mar 23 2023	SELL Open market or private sale	$8,954 $12.15 p/Share	737 Reduced 7.9%	8,597 Common Stock
Mar 22 2023	SELL Open market or private sale	$8,961 $12.64 p/Share	709 Reduced 7.06%	9,334 Common Stock
Mar 21 2023	SELL Open market or private sale	$8,752 $12.89 p/Share	679 Reduced 6.33%	10,043 Common Stock
Mar 20 2023	SELL Open market or private sale	$9,344 $12.61 p/Share	741 Reduced 6.46%	10,722 Common Stock
Mar 17 2023	SELL Open market or private sale	$10,557 $13.28 p/Share	795 Reduced 6.49%	11,463 Common Stock
Mar 16 2023	SELL Open market or private sale	$10,623 $13.43 p/Share	791 Reduced 6.06%	12,258 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	11,299 Added 46.41%	13,049 Common Stock
Oct 20 2020	BUY Conversion of derivative security	-	1,750 Added 50.0%	1,750 Common Stock

BRA

Bobak R. Azamian

President/CEO and Board Chair

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account